0001437749-23-002374.txt : 20230202
0001437749-23-002374.hdr.sgml : 20230202
20230202162516
ACCESSION NUMBER: 0001437749-23-002374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230201
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McIntyre Gail Frances
CENTRAL INDEX KEY: 0001492646
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36361
FILM NUMBER: 23581264
MAIL ADDRESS:
STREET 1: C/O FURIEX PHARMACEUTICALS, INC.
STREET 2: 3900 PARAMOUNT PARKWAY, SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aravive, Inc.
CENTRAL INDEX KEY: 0001513818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264106690
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 3730 KIRBY DRIVE, SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: 936-355-1910
MAIL ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 3730 KIRBY DRIVE, SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
FORMER COMPANY:
FORMER CONFORMED NAME: Versartis, Inc.
DATE OF NAME CHANGE: 20110223
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-02-01
0001513818
Aravive, Inc.
ARAV
0001492646
McIntyre Gail Frances
C/O ARAVIVE, INC., RIVER OAKS TOWER,
3730 KIRBY DRIVE, SUITE 1200
HOUSTON
TX
77098
1
1
CEO and President
Stock Option (Right to Buy)
1.67
2023-02-01
4
A
0
700000
0
A
2033-01-31
Common Stock
700000
700000
D
These options vest over three years with 50% vesting on the one-year anniversary of the date of grant and the remaining 50% vesting on a pro rata basis on a monthly basis over a two-year period commencing on the month following the one-year anniversary of the grant date.
/s/ Abel Svitavsky, Attorney-in-fact
2023-02-02